Keyphrases
Hepatocellular Carcinoma
100%
Anti-PD-1 Therapy
100%
HIF Inhibitors
100%
Hypoxia-inducible factor-1α (HIF-1α)
33%
Patient Mortality
16%
Tumor
16%
Gene Expression
16%
Hemoglobin
16%
HIF-2
16%
Angiogenesis
16%
Cancer Mortality
16%
Innate Immunity
16%
Adaptive Immunity
16%
Tumor Immunity
16%
Tumor Growth
16%
Natural Killer Cells
16%
Encoded Protein
16%
Hepatocellular Carcinoma Cells
16%
CD8+ T Cells
16%
Hematocrit
16%
Immunodeficient Mice
16%
Cancer Causes
16%
Glycolytic Metabolism
16%
Tumor Eradication
16%
Tumor Hypoxia
16%
Immune Evasion
16%
Diagnostic Biopsy
16%
Hepa1-6
16%
Immune Checkpoint Blockade
16%
Myeloid-derived Suppressor Cells
16%
Altered Gene Expression
16%
Low Molecular Weight Compounds
16%
Tumor-associated Macrophages
16%
Change in Appearance
16%
Breakthrough Therapy
16%
Tumor Immune Microenvironment
16%
Immunology and Microbiology
Mouse
100%
Gene Expression
66%
Hypoxia Inducible Factor 1
66%
Immunotherapy
33%
Innate Immune System
33%
Cancer Mortality
33%
Body Weight
33%
Adaptive Immune System
33%
Molecular Weight
33%
Natural Killer Cell
33%
Tumor-Associated Macrophage
33%
Carcinoma Cell
33%
Cytotoxic T-Cell
33%
Angiogenesis
33%
Hematocrit
33%
Immune Evasion
33%
Immune Checkpoint Blockade
33%
Myeloid-Derived Suppressor Cell
33%
Tumor Hypoxia
33%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Neoplasm
42%
Gene Expression
28%
Hypoxia Inducible Factor 1
28%
Biopsy
14%
Diagnosis
14%
Immunotherapy
14%
Angiogenesis
14%
Body Weight
14%
Tumor Progression
14%
Carcinoma Cell
14%
Macrophage
14%
Cytotoxic T-Cell
14%
Natural Killer Cell
14%
Cancer Mortality
14%
Innate Immunity
14%
Hematocrit
14%
Adaptive Immunity
14%
Immune Checkpoint Blockade
14%
Immune Evasion
14%
Myeloid-Derived Suppressor Cell
14%
Tumor Hypoxia
14%
Tumor Immune Microenvironment
14%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Neoplasm
57%
Mouse
42%
Hypoxia Inducible Factor 1
28%
Immunotherapy
14%
Hypoxia
14%
CD8 Antigen
14%
Tumor Growth
14%
Cancer Mortality
14%